with certain forms of congenital heart disease (CHD). Variability in prenatal diagnosis has been demonstrated in other countries, leading to efforts to improve fetal imaging protocols and access to care, but has not been examined across the United States. The objective was to evaluate national variation in prenatal detection across geographic region and defect type in neonates and infants with CHD undergoing heart surgery.
METHODS: Cardiovascular operations performed in patients #6 months of age in the United States and included in the Society of Thoracic Surgeons Congenital Heart Surgery Database (2006) (2007) (2008) (2009) (2010) (2011) (2012) were eligible for inclusion. Centers with .15% missing prenatal diagnosis data were excluded from the study. Prenatal diagnosis rates were compared across geographic location of residence and defect type using the x 2 test.
RESULTS: Overall, the study included 31 374 patients from 91 Society of Thoracic Surgeons Congenital Heart Surgery Database participating centers across the United States. Prenatal detection occurred in 34% and increased every year, from 26% (2006) to 42% (2012). There was significant geographic variation in rates of prenatal diagnosis across states (range 11.8%-53.4%, P , .0001). Significant variability by defect type was also observed, with higher rates for lesions identifiable on 4-chamber view than for those requiring outflow tract visualization (57% vs 32%, P , .0001).
CONCLUSIONS:
Rates of prenatal CHD detection in the United States remain low for patients undergoing surgical intervention, with significant variability between states and across defect type. Additional studies are needed to identify reasons for this variation and the potential impact on patient outcomes.
WHAT'S KNOWN ON THIS SUBJECT:
Prenatal diagnosis may lead to benefits in outcomes for certain forms of critical congenital heart disease. Despite recognized benefits, singlecenter studies and focused regional efforts suggest that prenatal detection rates for congenital heart disease remain low in the United States.
WHAT THIS STUDY ADDS:
We describe prenatal detection rates for a large cohort of neonates and infants undergoing heart surgery across a range of congenital heart defects. Additionally, this study adds new information by demonstrating geographic variability of prenatal detection rates across the United States.
Congenital heart disease (CHD) is the most common class of birth defect, affecting 8 in 1000 live births, with approximately one-quarter of these children needing intervention in the first year of life. [1] [2] [3] Advances in congenital heart surgery have improved survival rates for neonates and infants with CHD, and efforts are now being made to optimize perinatal and preoperative factors to promote improvements in outcomes. A diagnosis of CHD before birth allows prenatal counseling and coordination of delivery at an experienced cardiac center. Evidence now suggests that a prenatal diagnosis may lead to benefits in early postnatal status and outcomes in certain critical forms of CHD. 4, 5 Despite recognized benefits of prenatal CHD diagnosis and nearly universal availability of prenatal ultrasound, 6,7 recent single-center studies and focused regional efforts suggest that prenatal detection rates (PDRs) for CHD remain low in the United States. [8] [9] [10] [11] [12] [13] In other countries, large-scale assessments using birth registries have identified significant regional variability of prenatal CHD diagnosis. [14] [15] [16] Centralized prenatal health care efforts in these countries have led to implementation of protocols to improve access to care and standardization of fetal imaging. In the United States, assessments of national PDRs are lacking, and the extent of variation across regions has not been defined.
The purpose of this study was to provide a baseline assessment of national prenatal CHD detection rates and recent trends for a large cohort of neonates and infants undergoing heart surgery. We used a clinical registry to describe variation in the frequency of prenatal detection across the United States by geographic location and defect type. We also assessed the influence of noncardiac congenital anomalies and chromosomal abnormalities on PDRs.
METHODS

Data Source
The Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) was used for this study. It is estimated that the database represents ∼93% of all US centers that perform congenital heart surgery and .96% of all operations. 17 (Fig 1) . Sensitivity analysis including only the centers that participated in the database every year since 2006 confirmed similar trends, P , .0001.
Prenatal Detection Rates by Defect Type
PDRs were examined across several specific diagnoses (Table 2 ). There was significant variation of PDRs across defect type (P , .0001), with the highest detection rates for HLHS (67%) and the lowest detection rates for total anomalous pulmonary venous connection (9.1%). Defects associated with an abnormal 4CV were more likely to have prenatal identification than those with a normal 4CV (56.7% vs 32.2%, P , .0001; Fig 2) . The addition of a ventricular septal defect led to higher PDRs for lesions such as TGA, coarctation of the aorta, and pulmonary atresia. Additional PDRs for various CHD categories are shown in Table 2 .
Prenatal Detection in Those With Additional Noncardiac Anomalies
Noncardiac anatomic abnormalities, syndromes, or chromosomal abnormalities were found to be present in 10 037 (31.9%) of the overall cohort. These abnormalities were more common in the infant cohort (40.9%) than in the neonatal cohort (23.0%). Patients with additional abnormalities had higher PDRs (39% vs 32%, P # .0001). Similar trends were seen in both the neonate and infant subgroups (Table 3) . Figure 3 demonstrates PDRs for the 10 USDHHS regions. There was significant variation across regions, with PDRs ranging from 24% (95% confidence interval [CI], 22%-25%) in the "Dallas" region to 46% (95% CI, 44%-47%) in the "Philadelphia" region, P , .0001. There was also significant variation at the state level, with a wide range of PDRs, from a low of 11.8% (95% CI, 4.6%-19.1%) to a high of 53.4% (95% CI, 50.2%-56.5%), P , .0001 (Fig 4) .
Prenatal Detection by Geographic Location
DISCUSSION
We assessed PDRs for a large cohort of children with CHD undergoing heart surgery as neonates and infants across the United States. Our analysis of .31 000 patients from 47 states is the largest study to date assessing PDRs. In our cohort, patients with more critical forms of CHD necessitating surgery in the neonatal period had higher PDRs (43%) than those undergoing surgery as infants (24%). Our findings are consistent with recent smaller series in California, Nevada, Ohio, Atlanta, and Utah demonstrating CHD detection rates ranging from 10% to 43%, [8] [9] [10] [11] [12] [13] despite some differences in methods for selecting study populations across studies. Our current work confirms these findings on a national level with a large cohort of patients with CHD undergoing surgery.
A main goal of the study was to assess potential variability of PDRs across various types of cardiac anomalies. We demonstrated wide variability in PDRs across different anatomic diagnoses, with forms of CHD that have abnormalities amenable to identification on a screening ultrasound 4CV being diagnosed more frequently than those that require outflow tract views (OFTVs) for detection. When compared with recent studies in the United States, our PDRs for specific defect types are similar but with a larger cohort of patients (Table 4 ).
An additional goal of the study was to examine regional variability of PDRs. To the best of our knowledge
FIGURE 1
PDRs by year for neonatal (white bars) and infant (black bars) cohorts. N indicates the total number of subjects represented by each bar. this is the first study to examine this subject across the United States. In our cohort, there was significant variation across the country, by both region and state. Previous studies in other countries have assessed variation of PDRs. In Canada, variability by jurisdictions has been reported, and the authors suggested that differences in imaging skills and access to fetal echocardiography were potential causes. 16 Garne et al 14 used data from 20 European registries demonstrating a wide range of PDRs between countries and even between those with similar screening recommendations. Our current findings are similar in that regional variation is significant and probably multifactorial.
Study Implications
Anomalies of the cardiovascular system are the most common form of birth defect, 1 and perinatal death from CHD is the most common form of infant mortality. 23, 24 Therefore, effective screening for CHD before birth should be a public health priority in the United States. In an era of nearly universal availability of prenatal ultrasound, 8, 9, 11 these rates of prenatal CHD diagnosis are suboptimal in this important group of patients who need surgical intervention after birth. From our current data we do not know whether the missed opportunity for prenatal CHD detection results from an unnoticed diagnosis on the screening obstetric ultrasound or possibly a missed diagnosis at the level of a fetal echocardiogram. Previous studies have demonstrated very high sensitivities and specificities for detection of complex CHD by fetal echocardiography. 9, 11, 25 Additionally, fetal echocardiography requires an initial referral from the obstetric community. Therefore, the highest-yield strategies to increase detection rates in our current system should involve improvements to the midgestation obstetric screening ultrasound. Multiple factors are probably playing a role in missed CHD identification at the screening ultrasound level, including differences in skill set of the sonographer, experience and training of the physician performing the study, and issues related to access in certain regions to a pediatric cardiologist for fetal echocardiography.
In the United States current recommendations for low-risk pregnancies include a second trimester screening ultrasound to assess for fetal anomalies, 26 with the majority of these studies being performed by community-based physicians. 8 Previous studies have shown that variability in the number and timing of prenatal ultrasounds a patient receives is an important factor, with those lacking a detailed anatomic assessment being more likely to be associated with missed CHD detection. 11 Furthermore, it has been shown that communitybased obstetricians and radiologists do not always adhere to the complete components of screening ultrasounds, 27 and when risk factors for CHD are present, referral patterns for fetal echocardiography by a pediatric cardiologist appear to vary significantly. 9 Future efforts to increase prenatal CHD diagnosis rates should include an attempt to identify local barriers to improved adherence to prenatal cardiac screening protocols and referral guidelines for fetal echocardiography.
FIGURE 2
PDRs are demonstrated by defect visibility on 4CV (No/Yes). AV, atrioventricular; CC-TGA, congenitally corrected transposition of the great arteries; TGA/IVS, transposition of the great arteries with intact ventricular septum. Single-ventricle lesions include HLHS. Cohorts are grouped by whether a risk factor was present. A risk factor was defined as the presence of a noncardiac anomaly or genetic syndrome. PDRs are provided. A total of 536 patients were excluded from this analysis because of missing data. P represents the difference in PDRs based on presence or absence of a risk factor. 34 These studies may serve as a model for development of future collaborative fetal centers and provide data on how much improvement may be expected through educational programs aimed at sonographer training and increased use of OFTVs.
Study Limitations
This study was limited to patients eligible for enrollment in a cardiac surgical database. Therefore, we are presenting data on a large cohort of neonates and infants undergoing surgery. We were not able to include information on terminations or fetal demise. Additionally, infants who underwent catheter-based interventions or died with undetected CHD were also not included. Therefore, our PDRs are for a cohort of patients who undergo heart surgery and probably underestimate overall rates for all patients with CHD. In previous reports, fetal demise in fetuses with CHD was uncommon, 15 
FIGURE 3
The 10 USDHHS regions, with PDRs. Oregon, Nevada, and Utah did not have sufficient prenatal diagnosis data during study period to be included in the analysis.
FIGURE 4
PDRs by state. States in black (Oregon, Nevada, and Utah) did not have sufficient prenatal diagnosis data during study period to be included in the analysis. Total N, total number of patients included in each study. CoA, coarctation of the aorta; TGA, transposition of the great arteries. a Study reports only the overall percentages for PDRs; specific numbers of patients with each defect type not available. b Data reported in this study represent all forms of single-ventricle heart disease including HLHS.
